These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. Henry DA; Campbell ME; LiPuma JJ; Speert DP J Clin Microbiol; 1997 Mar; 35(3):614-9. PubMed ID: 9041399 [TBL] [Abstract][Full Text] [Related]
30. Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin. Messiaen AS; Nelis H; Coenye T J Cyst Fibros; 2014 Jan; 13(1):56-62. PubMed ID: 23932109 [TBL] [Abstract][Full Text] [Related]
31. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis. Walsh NM; Casano AA; Manangan LP; Sinkowitz-Cochran RL; Jarvis WR J Pediatr; 2002 Oct; 141(4):512-7. PubMed ID: 12378190 [TBL] [Abstract][Full Text] [Related]
32. A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia. Ledson MJ; Gallagher MJ; Robinson M; Cowperthwaite C; Williets T; Hart CA; Walshaw MJ J Aerosol Med; 2002; 15(1):51-7. PubMed ID: 12006145 [TBL] [Abstract][Full Text] [Related]
33. Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients. Millar-Jones L; Ryley HC; Paull A; Goodchild MC Respir Med; 1998 Feb; 92(2):178-83. PubMed ID: 9616509 [TBL] [Abstract][Full Text] [Related]
34. Misidentification of a genomovar of Burkholderia cepacia by recA restriction fragment length polymorphism. Moore JE; Millar BC; Xu J; Crowe M; Redmond AO; Elborn JS J Clin Pathol; 2002 Apr; 55(4):309-11. PubMed ID: 11919219 [TBL] [Abstract][Full Text] [Related]
35. [Burkholderia cepacia: a new pathogen causing nosocomial infections]. Lipowski D; Rzadkiewicz E; Czekalska-Lachowicz E Przegl Epidemiol; 2008; 62(1):7-17. PubMed ID: 18536220 [TBL] [Abstract][Full Text] [Related]
36. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. Vandamme P; Henry D; Coenye T; Nzula S; Vancanneyt M; LiPuma JJ; Speert DP; Govan JR; Mahenthiralingam E FEMS Immunol Med Microbiol; 2002 Jun; 33(2):143-9. PubMed ID: 12052570 [TBL] [Abstract][Full Text] [Related]
37. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. De Soyza A; McDowell A; Archer L; Dark JH; Elborn SJ; Mahenthiralingam E; Gould K; Corris PA Lancet; 2001 Nov; 358(9295):1780-1. PubMed ID: 11734238 [TBL] [Abstract][Full Text] [Related]
38. Occurrence of Burkholderia cepacia in the hospital environment. Moore JE; McIlhatton B; Buchanan J; Gilpin D; Shaw A; Hall V; Murphy PG; Elborn JS Ir J Med Sci; 2002; 171(3):131-3. PubMed ID: 15736349 [TBL] [Abstract][Full Text] [Related]